A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers.
http://ift.tt/1j8sD5D
http://ift.tt/1j8sD5D
No comments:
Post a Comment